82 FR 29329 - Notice Pursuant to the National Cooperative Research and Production Act of 1993-fd.io Project, Inc.
DEPARTMENT OF JUSTICE
Antitrust Division Federal Register Volume 82, Issue 123 (June 28, 2017)
Antitrust Division
Federal Register Volume 82, Issue 123 (June 28, 2017)
| Page Range | 29329-29329 | |
| FR Document | 2017-13553 |
[Federal Register Volume 82, Number 123 (Wednesday, June 28, 2017)] [Notices] [Page 29329] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-13553] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993--fd.io Project, Inc. Notice is hereby given that, on May 30, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), fd.io Project, Inc. (``fd.io'') has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ZTE Corporation, Shenzhen, People's Republic of China, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and fd.io intends to file additional written notifications disclosing all changes in membership. On May 4, 2016, fd.io filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2016 (81 FR 37211). The last notification was filed with the Department on March 6, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on March 27, 2017 (82 FR 15240). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017-13553 Filed 6-27-17; 8:45 am] BILLING CODE P
![Federal Register / Vol. 82, No. 123 / Wednesday, June 28, 2017 / Notices 29329
On October 17, 2014, Open Platform Register pursuant to Section 6(b) of the On February 24, 2017, a Diversion
for NFV Project filed its original Act on March 27, 2017 (82 FR 15240). Investigator from the Jackson,
notification pursuant to Section 6(a) of Mississippi District Office personally
Patricia A. Brink,
the Act. The Department of Justice served the Show Cause Order on
Director of Civil Enforcement, Antitrust
published a notice in the Federal Registrant at his residence in West
Division.
Register pursuant to Section 6(b) of the Point, Mississippi. GX 4 (Declaration of
[FR Doc. 2017–13553 Filed 6–27–17; 8:45 am]
Act on November 14, 2014 (79 FR Diversion Investigator).
68301).
BILLING CODE P On May 5, 2017, the Government
forwarded its Request for Final Agency
The last notification was filed with Action (RFAA) and an evidentiary
the Department on March 9, 2017. A DEPARTMENT OF JUSTICE record to my Office. Therein, the
notice was published in the Federal Government represents that Registrant
Drug Enforcement Administration
Register pursuant to Section 6(b) of the ‘‘has not filed a request for a hearing or
Act on April 4, 2017 (82 FR 16419). John Warren Cox, M.D.; Decision and a written statement, and more than 30
Order days ha[ve] now passed since he was
Patricia A. Brink,
served.’’ RFAA, at 1–2.
Director of Civil Enforcement, Antitrust On February 23, 2017, the Assistant Based on the Government’s
Division. Administrator, Diversion Control representation that more than 30 days
[FR Doc. 2017–13555 Filed 6–27–17; 8:45 am] Division, Drug Enforcement have now passed since the date of
BILLING CODE P Administration (DEA), issued an Order service of the Show Cause Order and
to Show Cause to John Warren Cox, that Registrant has not submitted a
M.D. (Registrant), of West Point, request for a hearing or a written
DEPARTMENT OF JUSTICE Mississippi. GX 2. The Show Cause statement, I find that Registrant has
Order proposed the revocation of waived his right to a hearing or to
Antitrust Division Registrant’s DEA Certificate of submit a written statement in lieu of a
Registration No. BC6115047, on the hearing. 21 CFR 1301.43(d). I therefore
Notice Pursuant to the National ground that he does not have authority issue this Decision and Final Order
Cooperative Research and Production to handle controlled substances in based on relevant evidence contained in
Act of 1993—fd.io Project, Inc. Mississippi, the State in which he is the record submitted by the
registered with the Agency. Id. at 1 Government. Id. § 1301.43(d) & (e). I
Notice is hereby given that, on May (citing 21 U.S.C. 824(a)(3)). make the following findings of fact.
30, 2017, pursuant to Section 6(a) of the With respect to the Agency’s
jurisdiction, the Show Cause Order Findings
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301 alleged that Registrant is registered with Registrant is the holder of DEA
et seq. (‘‘the Act’’), fd.io Project, Inc. the DEA as a practitioner authorized to Registration No. BC6115047, pursuant
(‘‘fd.io’’) has filed written notifications handle controlled substances in to which he is authorized to dispense
simultaneously with the Attorney schedules II through V under DEA controlled substances in Schedules II
General and the Federal Trade registration BC6115047, at the registered through V as a practitioner, at the
Commission disclosing changes in its address of 187 Medical Center Drive, registered address of 187 Medical Center
membership. The notifications were West Point, Mississippi. Id. The Order Drive, West Point, Mississippi. GX 1
alleged that Registrant’s registration (Certification of Registration History).
filed for the purpose of extending the
expires by its terms on August 31, 2019. His registration does not expire until
Act’s provisions limiting the recovery of
Id. August 31, 2019. Id.
antitrust plaintiffs to actual damages As to the substantive ground for the On October 18, 2016, Registrant
under specified circumstances. proceeding, the Show Cause Order voluntarily surrendered his license to
Specifically, ZTE Corporation, specifically alleged that on October 18, practice medicine in the State of
Shenzhen, People’s Republic of China, 2016, Registrant ‘‘voluntarily Mississippi, and ‘‘agree[d] to never seek
has been added as a party to this surrendered [his] Mississippi medical application for a future license to
venture. license and agreed to never again seek practice medicine in the State of
No other changes have been made in to be licensed in the State of Mississippi.’’ GX 3, at 2 (Surrender of
either the membership or planned Mississippi.’’ Id. The Show Cause Order Medical License). The agreement to
activity of the group research project. further alleged that because Registrant is voluntarily surrender his license
Membership in this group research currently without authority to practice followed an investigation by the
project remains open, and fd.io intends medicine or handle controlled Investigative Division of the Mississippi
to file additional written notifications substances in the State of Mississippi, State Board of Medical Licensure, which
disclosing all changes in membership. ‘‘the DEA must revoke [his] DEA COR.’’ ‘‘ha[d] in its possession evidence which,
Id. at 2 (citing 21 U.S.C. 823(f) and if produced during the course of an
On May 4, 2016, fd.io filed its original 824(a)(3) (other citations omitted)). evidentiary hearing, would show [that
notification pursuant to Section 6(a) of The Show Cause Order notified Registrant’s] continued practice
the Act. The Department of Justice Registrant of his right to request a constitutes a threat to the public health
published a notice in the Federal
asabaliauskas on DSKBBXCHB2PROD with NOTICES
hearing on the allegations, or to submit and safety due to his impairment.’’ Id.
Register pursuant to Section 6(b) of the a written statement in lieu of a hearing, at 2. Registrant’s surrender became
Act on June 9, 2016 (81 FR 37211). the procedure for electing either option, effective immediately upon execution of
The last notification was filed with and the consequence for failing to elect the surrender form on October 18, 2016.
the Department on March 6, 2017. A either option. Id. at 2 (citing 21 CFR Id.
notice was published in the Federal 1301.43). It also notified him of his right A printout from the Mississippi
to submit a corrective action plan in Board’s Physician Profile System, dated
accordance with 21 U.S.C. 824(c)(2)(C). May 5, 2017, shows that Registrant’s
Id. at 2–3. license to practice medicine ‘‘expired’’
VerDate Sep<11>2014 17:22 Jun 27, 2017 Jkt 241001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\28JNN1.SGM 28JNN1](https://thefederalregister.org/doc/82_FR_29452/page/1.svg)
Document Created: 2017-06-28 01:10:23
Document Modified: 2017-06-28 01:10:23
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 82 FR 29329 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR